Story perspectives

Prof. Whitty: Obesity Crisis Demands Policy Over Pills

3/6/2026

Summary

Story summary

Prof. Chris Whitty, the U.K.’s chief medical adviser, criticizes reliance on weight-loss drugs like GLP-1 agonists, saying they have side effects and miss root causes.
He calls for stronger public health measures, including regulating junk-food advertising and reformulating unhealthy products.
Whitty notes decades of UK obesity policy have failed, unlike France's successes.
Experts agree weight-loss drugs should not replace policy; proactive measures are needed to prevent childhood obesity.

1 of 1

Story summary

Prof. Chris Whitty, the U.K.’s chief medical adviser, criticizes reliance on weight-loss drugs like GLP-1 agonists, saying they have side effects and miss root causes.
He calls for stronger public health measures, including regulating junk-food advertising and reformulating unhealthy products.
Whitty notes decades of UK obesity policy have failed, unlike France's successes.
Experts agree weight-loss drugs should not replace policy; proactive measures are needed to prevent childhood obesity.